
Paul A Cullis MD
Movement Disorder, Vascular Neurology
Chief of Neurology, Ascension Michigan
Join to View Full Profile
285 N Deere Park Dr EHighland Park, IL 60035
Phone+1 586-530-1338
Fax+1 847-748-8006
Dr. Cullis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Cullis is a neurologist based in Highland Park, IL, with subspecialties in movement disorders and vascular neurology. He completed his education with a fellowship in vascular neurology and a neurology residency at Detroit Medical Center/Wayne State University, following his medical degree from Birmingham University Medical School in 1979. Dr. Cullis served as the Section Chief at Henry Ford St. John Hospital since 1998 and is experienced in amyloid neuropathy, movement disorders, and cerebrovascular disease. He has published several notable research papers, including studies on tenecteplase in acute ischemic stroke and botulinum toxin in cervical dystonia. His work has been recognized with honors such as Super Doctor and Top MD.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Neurology, 1980 - 1984
Birmingham University Medical SchoolClass of 1979
Detroit Medical Center/Wayne State UniversityFellowship, Vascular Neurology
Certifications & Licensure
FL State Medical License 1992 - 2027
MI State Medical License 1981 - 2027
WI State Medical License 2021 - 2027
IL State Medical License 2022 - 2026
TN State Medical License 2025 - 2026
AL State Medical License 2023 - 2023
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 59 citationsSymptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alt...Steven J Warach, Anna Ranta, Joosup Kim, Shlee S Song, Adam Wallace
JAMA Neurology. 2023-07-01 - 26 citationsCervical dystonia severity scale reliability study.Christopher F. O'Brien, Allison Brashear, Paul A. Cullis, Daniel D. Truong, Eric Molho
Movement Disorders. 2001-11-01 - 16 citationsBotulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.Paul A. Cullis, C. F. O'brien, Daniel D. Truong, M. Koller, T. P. Villegas
Advances in Neurology. 1998-01-01
Press Mentions
Newer Generation, Clot-Busting Stroke Medication Cuts the Risk of Serious Bleeding in HalfFebruary 3rd, 2022
Stroke Risk Plummets with Healthy LifestyleAugust 11th, 2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









